{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:22:14Z","timestamp":1790360534590,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Biomedical Joint Funding of Guizhou Provincial Science and Technology Department","award":["No. Qiankehe LH Zi [2017] 7109"],"award-info":[{"award-number":["No. Qiankehe LH Zi [2017] 7109"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies have shown that insulin resistance is strongly associated with the development of cardiovascular disease, and the triglyceride glucose-body mass index (TyG-BMI index) is considered to be a reliable surrogate marker of insulin resistance. There are limited studies on the relationship between TyG-BMI index and the extent of coronary artery disease in patients with acute coronary syndrome (ACS). This study aimed to investigate the relationship between TyG-BMI index and the extent of coronary artery disease in patients with ACS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Overall, 2,317 patients with ACS who underwent percutaneous coronary intervention at the Affiliated Hospital of Zunyi Medical University were included in this study. The TyG-BMI index was grouped according to the tertile method. The extent of coronary artery disease in patients with ACS was quantitatively assessed using the SYNTAX score, which was categorised as low (\u2264\u200922), intermediate (23\u201332), and high risk (\u2265\u200933).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the overall population, multivariate logistic regression analyses showed that TyG-BMI index was associated with mid\/high SYNTAX score in patients with ACS (odds ratio [OR]\u2009=\u20091.0041; 95% confidence interval [CI]\u2009=\u20091.0000\u20131.0079;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0310). Subgroup analyses showed that TyG-BMI index was an independent risk factor for mid\/high SYNTAX score in female ACS patients after adjusting for multiple confounders (OR\u2009=\u20091.0100; 95% CI\u2009=\u20091.0000\u20131.0200;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0050), and that the risk of mid\/high SYNTAX score was 2.49 times higher in the T3 group (OR\u2009=\u20092.4900; 95% CI\u2009=\u20091.2200\u20135.0600;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0120). Restricted cubic spline analysis showed a linear correlation between TyG-BMI index and complex coronary artery disease (SYNTAX score\u2009&gt;\u200922) in women with ACS. In female ACS patients, inclusion of the TyG-BMI index did not improve the predictive power of the underlying risk model (net reclassification improvement: 0.0867 [-0.0256\u20130.1989],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.1301; integrated discrimination improvement: 0.0183 [0.0038\u20130.0329],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0135).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TyG-BMI index is linearly associated with the degree of complex coronary artery disease in female ACS patients. However, the inclusion of the TyG-BMI index did not improve the predictive power of the underlying risk model for female ACS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-024-02124-2","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T06:02:17Z","timestamp":1705125737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes"],"prefix":"10.1186","volume":"23","author":[{"given":"Xueyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanxue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"issue":"10332","key":"2124_CR1","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(21)02391-6","volume":"399","author":"BA Bergmark","year":"2022","unstructured":"Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347\u201358.","journal-title":"Lancet"},{"issue":"7","key":"2124_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/jama.284.7.876","volume":"284","author":"EM Ohman","year":"2000","unstructured":"Ohman EM, Granger CB, Harrington RA, Lee KL. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA. 2000;284(7):876\u20138.","journal-title":"JAMA"},{"issue":"8","key":"2124_CR3","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153\u2013e639.","journal-title":"Circulation"},{"issue":"38","key":"2124_CR4","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"key":"2124_CR5","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.","journal-title":"Metabolism"},{"issue":"6","key":"2124_CR6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"issue":"8","key":"2124_CR7","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan TJE, Harbuwono DS, Purnamasari D, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and tryglyceride\/glucose index. Diabetes Metab Syndr. 2022;16(8):102581.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"2124_CR8","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","volume":"93","author":"AC Vasques","year":"2011","unstructured":"Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98\u2013e100.","journal-title":"Diabetes Res Clin Pract"},{"key":"2124_CR9","doi-asserted-by":"crossref","unstructured":"Luo P, Cao Y, Li P, Li W, Song Z, Fu Z, Zhou H, Yi X, Zhu L, Zhu S. TyG index performs better than HOMA-IR in Chinese type 2 diabetes mellitus with a BMI\u2009<\u200935 kg\/m2: a hyperglycemic clamp validated study. Med (Kaunas). 2022;58(7).","DOI":"10.3390\/medicina58070876"},{"issue":"1","key":"2124_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","volume":"20","author":"X Ding","year":"2021","unstructured":"Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2124_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Jin P, Wang F. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2124_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J, Fan H, Wang T, Yu B, Mao S, Wang X, Zhang W, Wang L, Zhang Y, Ren Z, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2124_CR13","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2337\/dc18-1920","volume":"42","author":"K Park","year":"2019","unstructured":"Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, Kim JH, Park JS. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569\u201373.","journal-title":"Diabetes Care"},{"issue":"1","key":"2124_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12933-022-01615-4","volume":"21","author":"J Wang","year":"2022","unstructured":"Wang J, Huang X, Fu C, Sheng Q, Liu P. Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome. Cardiovasc Diabetol. 2022;21(1):187.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2124_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12933-023-01780-0","volume":"22","author":"S Xiong","year":"2023","unstructured":"Xiong S, Chen Q, Long Y, Su H, Luo Y, Liu H, Chen Y, Feng Q, Peng X, Jiang M, et al. Association of the triglyceride-glucose index with coronary artery disease complexity in patients with acute coronary syndrome. Cardiovasc Diabetol. 2023;22(1):56.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2124_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12933-017-0589-4","volume":"16","author":"MK Kim","year":"2017","unstructured":"Kim MK, Ahn CW, Kang S, Nam JS, Kim KR, Park JS. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16(1):108.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2124_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-022-01523-7","volume":"21","author":"J Su","year":"2022","unstructured":"Su J, Li Z, Huang M, Wang Y, Yang T, Ma M, Ni T, Pan G, Lai Z, Li C, et al. Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022;21(1):96.","journal-title":"Cardiovasc Diabetol"},{"key":"2124_CR18","doi-asserted-by":"publisher","first-page":"111315","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"2124_CR19","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93\u2013e621.","journal-title":"Circulation"},{"issue":"3","key":"2124_CR20","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007\u20132010 Korean national health and nutrition examination survey. PLoS ONE. 2019;14(3):e0212963.","journal-title":"PLoS ONE"},{"key":"2124_CR21","doi-asserted-by":"crossref","unstructured":"Huang YC, Huang JC, Lin CI, Chien HH, Lin YY, Wang CL, Liang FW, Dai CY, Chuang HY. Comparison of innovative and traditional cardiometabolic indices in estimating atherosclerotic Cardiovascular Disease risk in adults. Diagnostics (Basel). 2021;11(4).","DOI":"10.3390\/diagnostics11040603"},{"key":"2124_CR22","doi-asserted-by":"crossref","unstructured":"Cho YK, Lee J, Kim HS, Kim EH, Lee MJ, Yang DH, Kang JW, Jung CH, Park JY, Kim HK et al. Triglyceride Glucose-Waist Circumference Better Predicts Coronary Calcium Progression Compared with other indices of insulin resistance: a longitudinal observational study. J Clin Med. 2020;10(1).","DOI":"10.3390\/jcm10010092"},{"issue":"1","key":"2124_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12872-020-01768-8","volume":"20","author":"Z Du","year":"2020","unstructured":"Du Z, Xing L, Lin M, Sun Y. Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population. BMC Cardiovasc Disord. 2020;20(1):483.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2124_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13098-022-00967-x","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang R, Fu X, Song H. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease. Diabetol Metab Syndr. 2022;14(1):191.","journal-title":"Diabetol Metab Syndr"},{"issue":"10","key":"2124_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMoa0804626","volume":"360","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, St\u00e5hle E, Feldman TE, van den Brand M, Bass EJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961\u201372.","journal-title":"N Engl J Med"},{"issue":"6","key":"2124_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2124_CR27","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.","journal-title":"PLoS ONE"},{"issue":"7","key":"2124_CR28","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2337\/dc09-9033","volume":"32","author":"International Expert Committee report on the","year":"2009","unstructured":"International Expert Committee report on the. Role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327\u201334.","journal-title":"Diabetes Care"},{"issue":"10033","key":"2124_CR29","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","volume":"387","author":"JR Beard","year":"2016","unstructured":"Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, Lloyd-Sherlock P, Epping-Jordan JE, Peeters G, Mahanani WR, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145\u201354.","journal-title":"Lancet"},{"issue":"6","key":"2124_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tcm.2006.03.008","volume":"16","author":"C Morisco","year":"2006","unstructured":"Morisco C, Lembo G, Trimarco B. Insulin resistance and cardiovascular risk: new insights from molecular and cellular biology. Trends Cardiovasc Med. 2006;16(6):183\u20138.","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"2124_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293\u2013302.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2124_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","volume":"22","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2124_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-023-01898-1","volume":"22","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):161.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2124_CR34","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.2337\/diacare.27.12.2898","volume":"27","author":"A Juutilainen","year":"2004","unstructured":"Juutilainen A, Kortelainen S, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27(12):2898\u2013904.","journal-title":"Diabetes Care"},{"issue":"9","key":"2124_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41569-019-0211-4","volume":"16","author":"T Gagliano-Juc\u00e1","year":"2019","unstructured":"Gagliano-Juc\u00e1 T, Basaria S. Testosterone replacement therapy and cardiovascular risk. Nat Rev Cardiol. 2019;16(9):555\u201374.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"2124_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrendo.2013.122","volume":"9","author":"PM Rao","year":"2013","unstructured":"Rao PM, Kelly DM, Jones TH. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol. 2013;9(8):479\u201393.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2124_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/14779072.2019.1561277","volume":"17","author":"H Wada","year":"2019","unstructured":"Wada H, Miyauchi K, Daida H. Gender differences in the clinical features and outcomes of patients with coronary artery disease. Expert Rev Cardiovasc Ther. 2019;17(2):127\u201333.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"2124_CR38","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ijo.2008.25","volume":"32","author":"JC Lovejoy","year":"2008","unstructured":"Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949\u201358.","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"2124_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(22)00142-5","volume":"10","author":"The Lancet Diabetes E","year":"2022","unstructured":"The Lancet Diabetes E. Menopause: a turning point for women\u2019s health. Lancet Diabetes Endocrinol. 2022;10(6):373.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"2124_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jacc.2013.06.047","volume":"62","author":"M Yadav","year":"2013","unstructured":"Yadav M, Palmerini T, Caixeta A, Madhavan MV, Sanidas E, Kirtane AJ, Stone GW, G\u00e9n\u00e9reux P. Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. J Am Coll Cardiol. 2013;62(14):1219\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"2124_CR41","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.jacc.2011.02.032","volume":"57","author":"T Palmerini","year":"2011","unstructured":"Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute catheterization and urgent intervention triage StrategY) trial. J Am Coll Cardiol. 2011;57(24):2389\u201397.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2124_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jcin.2010.09.017","volume":"4","author":"S Garg","year":"2011","unstructured":"Garg S, Sarno G, Serruys PW, Rodriguez AE, Bolognese L, Anselmi M, De Cesare N, Colangelo S, Moreno R, Gambetti S, et al. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (single high-dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute myocardial infarction) and MULTISTRATEGY (multicenter evaluation of single high-dose Bolus Tirofiban Versus Abciximab with Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC Cardiovasc Interv. 2011;4(1):66\u201375.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2124_CR43","first-page":"197","volume":"6","author":"L Askin","year":"2022","unstructured":"Askin L, Tanriverdi O. The clinical value of syntax scores in predicting coronary artery disease outcomes. Cardiovasc Innovations Appl. 2022;6(2):197\u2013208.","journal-title":"Cardiovasc Innovations Appl"},{"issue":"1","key":"2124_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/hrt.2007.134114","volume":"95","author":"E Romagnoli","year":"2009","unstructured":"Romagnoli E, Burzotta F, Trani C, Siviglia M, Biondi-Zoccai GG, Niccoli G, Leone AM, Porto I, Mazzari MA, Mongiardo R, et al. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart. 2009;95(1):43\u20138.","journal-title":"Heart"},{"issue":"6","key":"2124_CR45","first-page":"455","volume":"46","author":"L A\u015fk\u0131n","year":"2018","unstructured":"A\u015fk\u0131n L, Akt\u00fcrk E. Association between SYNTAX II score and electrocardiographic evidence of no-reflow in patients with ST-segment elevation myocardial infarction. Turk Kardiyol Dern Ars. 2018;46(6):455\u201363.","journal-title":"Turk Kardiyol Dern Ars"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02124-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T07:02:22Z","timestamp":1705129342000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02124-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2124"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02124-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3615542\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Affiliated Hospital of Zunyi Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}